Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
+5.73M
-
Total reported value, excl. options
-
$770M
-
Value change
-
+$132M
-
Number of buys
-
67
-
Number of sells
-
-23
-
Price
-
$22.69
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2016
101 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2016.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
of 49.8M outstanding shares and own 68.14% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (8.73M shares), BAUPOST GROUP LLC/MA (7.35M shares), FMR LLC (3.28M shares), VANGUARD GROUP INC (2.45M shares), BlackRock Fund Advisors (1.79M shares), Cormorant Asset Management, LLC (1.12M shares), FIRST MANHATTAN CO (1.02M shares), BlackRock Institutional Trust Company, N.A. (806K shares), STATE STREET CORP (710K shares), and Rock Springs Capital Management LP (700K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.